Cargando…

Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats

As one of the most lethal stroke subtypes, intracerebral hemorrhage (ICH) is acknowledged as a serious clinical problem lacking effective treatment. Available evidence from preclinical and clinical studies suggests that inflammatory mechanisms are involved in the progression of ICH-induced secondary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dengli, Liu, Keyue, Wake, Hidenori, Teshigawara, Kiyoshi, Mori, Shuji, Nishibori, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385548/ https://www.ncbi.nlm.nih.gov/pubmed/28393932 http://dx.doi.org/10.1038/srep46243

Ejemplares similares

Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats
por: Haruma, Jun, et al.
Publicado: (2016)

Histamine induced high mobility group box-1 release from vascular endothelial cells through H(1) receptor
por: Gao, Shangze, et al.
Publicado: (2022)

Histidine-Rich Glycoprotein Inhibits High-Mobility Group Box-1-Mediated Pathways in Vascular Endothelial Cells through CLEC-1A
por: Gao, Shangze, et al.
Publicado: (2020)

HMGB1 Translocation in Neurons after Ischemic Insult: Subcellular Localization in Mitochondria and Peroxisomes
por: Wang, Dengli, et al.
Publicado: (2020)

Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice
por: Fu, Li, et al.
Publicado: (2017)

High Mobility Group Box-1 and Blood–Brain Barrier Disruption
por: Nishibori, Masahiro, et al.
Publicado: (2020)

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb
por: Wang, Dengli, et al.
Publicado: (2022)

Histidine‐rich glycoprotein ameliorates endothelial barrier dysfunction through regulation of NF‐κB and MAPK signal pathway
por: Gao, Shangze, et al.
Publicado: (2019)

Pretreatment with High Mobility Group Box-1 Monoclonal Antibody Prevents the Onset of Trigeminal Neuropathy in Mice with a Distal Infraorbital Nerve Chronic Constriction Injury
por: Kochi, Takahiro, et al.
Publicado: (2021)

Histidine‐rich glycoprotein augments natural killer cell function by modulating PD‐1 expression via CLEC‐1B
por: Nishimura, Yoshito, et al.
Publicado: (2019)

Histidine-Rich Glycoprotein Suppresses Hyperinflammatory Responses of Lung in a Severe Acute Pancreatitis Mouse Model
por: Terao, Kinya, et al.
Publicado: (2018)

Corticosterone Induces HMGB1 Release in Primary Cultured Rat Cortical Astrocytes: Involvement of Pannexin-1 and P2X7 Receptor-Dependent Mechanisms
por: Hisaoka-Nakashima, Kazue, et al.
Publicado: (2020)

Phagocytosis of Advanced Glycation End Products (AGEs) in Macrophages Induces Cell Apoptosis
por: Gao, Yuan, et al.
Publicado: (2017)

Repeated Social Defeat Stress Induces HMGB1 Nuclear Export in Prefrontal Neurons, Leading to Social Avoidance in Mice
por: Kitaoka, Shiho, et al.
Publicado: (2023)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation
por: Wake, Hidenori, et al.
Publicado: (2016)

PT630. Influence of HMGB1 signaling in the global cerebral ischemia-induced mechanical allodynia
por: Matsuura, Wataru, et al.
Publicado: (2016)

Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice
por: Nosaka, Nobuyuki, et al.
Publicado: (2015)

Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1
por: Nakamura, Yoki, et al.
Publicado: (2013)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2
por: Yakabe, K, et al.
Publicado: (2005)

Anti-high mobility group box 1 monoclonal antibody suppressed hyper-permeability and cytokine production in human pulmonary endothelial cells infected with influenza A virus
por: Namba, Takahiro, et al.
Publicado: (2021)

Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro
por: Sun, Qing, et al.
Publicado: (2014)

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
por: Chen, Qingjie, et al.
Publicado: (2016)

Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2014)

Developmental expression of high-mobility group box 1 (HMGB1) in the mouse cochlea
por: Liu, Wenjing, et al.
Publicado: (2023)

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
por: Abdulahad, Deena A, et al.
Publicado: (2011)

Leukocyte‐Derived High‐Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes
por: Volmari, Annika, et al.
Publicado: (2021)

Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
por: Watanabe, Haruki, et al.
Publicado: (2017)

High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
por: Yuan, Shunling, et al.
Publicado: (2020)

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review
por: Ikram, Fathimath Zaha, et al.
Publicado: (2022)

High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy
por: DeWulf, Bram, et al.
Publicado: (2023)

Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
por: Tsubota, Maho, et al.
Publicado: (2019)

Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice
por: Tsubota, Maho, et al.
Publicado: (2021)

Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity
por: Horiuchi, Takahiro, et al.
Publicado: (2017)

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
por: Pisetsky, David S, et al.
Publicado: (2008)

High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
por: Ge, Xiaodong, et al.
Publicado: (2014)

The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet
por: Montes, V N, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7b31uvi0afvi7lsjm4jrjan4d9